Beyond the positive correlation found between the elevated PD-L1 expression in recovered TAMs and increased survival of GBM patients in this study, it is necessary to observe the curious negative correlation found between low patient survival and a high expression of the CD86 marker. The gene discussed is CD86; the disease is glioblastoma.